Pancreatic Cancer Action Network

Pancreatic Cancer Action Network
Founded 1999
Website www.pancan.org

The Pancreatic Cancer Action Network (PCAN) is a United States-based 501(c)3 charity[1] that funds research,[2] provides patient support, conducts community outreach,[3] and advocates for increased federal research funding for the prevention, diagnosis and treatment of pancreatic cancer. It was established in 1999, and has raised awareness for pancreatic cancer with the help of businesses and other groups.[4] [5] [6] [7] [8]

The network raises funds for pancreatic cancer research through its "Purple Stride" walkathons, which are organized by its affiliates in various local communities.[9][10]

Staff

In 2013, the President and CEO of the organization is Julie Fleshman.[11]

References

  1. ↑ "Pancreatic Cancer Action Network - Charity Reports - Give.org". Bbb.org. 2011-06-30. Retrieved 2013-11-18.
  2. ↑ "CATCHING HEALTH: Taking action against pancreatic cancer". Maine Women.
  3. ↑ "Austin’s yellow cabs turn pink, purple". Austin Business Journal. Bizjournals.com. Retrieved 2013-11-18.
  4. ↑ "Pancreatic Cancer Action Network–AACR Pathway to Leadership Grants". Newswise.com. 2012-03-15. Retrieved 2013-11-18.
  5. ↑ "Medical expert discusses pancreatic cancer - The Washington Post". Live.washingtonpost.com. 2011-10-06. Retrieved 2013-11-18.
  6. ↑ "NHLPA, NHL net more than $850,000 for cancer organizations during Hockey Fights Cancer™ Awareness Month in October - Hockey Fights Cancer". Nhl.com. 2011-11-21. Retrieved 2013-11-18.
  7. ↑ "Chicago skyline going purple for pancreatic cancer". The State Journal-Register (Springfield, Illinois). November 5, 2011. Retrieved 2013-11-18.
  8. ↑ "The Pancreatic Cancer Action Network and AACR to Award More Than $3.1 Million in Pancreatic Cancer Research Grants". Aacr.org. Retrieved 2013-11-18.
  9. ↑ "Runners, Walkers Fight Pancreatic Cancer". WBAL News Radio.
  10. ↑ "PurpleStride walk raises money for pancreatic cancer research". Jacksonville.com.
  11. ↑ "FDA Approves Novartis Drug Afinitor To Treat Pancreatic Neuroendocrine Tumors". Medical News Today. 2011-05-07. Retrieved 2013-11-18.

External links

This article is issued from Wikipedia - version of the Saturday, November 22, 2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.